Morphic (MORF) Stock Forecast, Price Target & Predictions
MORF Stock Forecast
Morphic stock forecast is as follows: an average price target of $57.00 (represents a 0.02% upside from MORF’s last price of $56.99) and a rating consensus of 'Hold', based on 6 wall street analysts offering a 1-year stock forecast.
MORF Price Target
MORF Analyst Ratings
Hold
Morphic Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jul 22, 2024 | Alex Thompson | Stifel Nicolaus | $57.00 | $56.52 | 0.85% | 0.02% |
Jul 13, 2024 | Michael Yee | Jefferies | $57.00 | $55.78 | 2.19% | 0.02% |
Jul 08, 2024 | Edward Nash | Canaccord Genuity | $57.00 | $55.74 | 2.26% | 0.02% |
Mar 13, 2024 | Michael Yee | Jefferies | $60.00 | $34.60 | 73.41% | 5.28% |
10
Morphic Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 4 |
Avg Price Target | - | - | $57.75 |
Last Closing Price | $56.99 | $56.99 | $56.99 |
Upside/Downside | -100.00% | -100.00% | 1.33% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jul 13, 2024 | Jefferies | - | Hold | Downgrade |
Jul 09, 2024 | Cowen & Co. | - | Hold | Downgrade |
Jul 09, 2024 | RBC Capital | Outperform | Sector Perform | Downgrade |
Jul 08, 2024 | BMO Capital | - | Market Perform | Downgrade |
Sep 25, 2023 | Needham | - | Hold | Initialise |
Feb 25, 2022 | RBC Capital | Outperform | Outperform | Hold |
Mar 07, 2021 | Wells Fargo | Overweight | Overweight | Hold |
10
Morphic Financial Forecast
Morphic Revenue Forecast
Quarter
Dec 24 | Sep 24 | Jun 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | $521.00K | $6.13M | $2.06M | $60.24M | $2.38M | $9.56M | $3.12M | $3.85M | $3.27M | $5.90M | $25.76M | $7.69M | $5.59M | $-334.00K | $5.67M | $5.57M |
Avg Forecast | $750.00K | $250.00K | - | $1.98M | $1.33M | $2.40M | $2.16M | $3.04M | $3.48M | $3.65M | $3.75M | $14.86M | $5.19M | $5.80M | $7.83M | $6.62M | $12.30M | $5.57M | $4.47M | $5.77M | $5.03M | $470.78K |
High Forecast | $750.00K | $250.00K | - | $2.38M | $1.33M | $2.40M | $2.16M | $3.04M | $3.48M | $3.65M | $3.75M | $14.86M | $5.19M | $5.80M | $7.83M | $6.62M | $12.30M | $5.57M | $4.47M | $5.77M | $5.03M | $564.94K |
Low Forecast | $750.00K | $250.00K | - | $1.58M | $1.33M | $2.40M | $2.16M | $3.04M | $3.48M | $3.65M | $3.75M | $14.86M | $5.19M | $5.80M | $7.83M | $6.62M | $12.30M | $5.57M | $4.47M | $5.77M | $5.03M | $376.62K |
# Analysts | 1 | 1 | - | 18 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 8 |
Surprise % | - | - | - | - | - | - | 0.24% | 2.02% | 0.59% | 16.48% | 0.63% | 0.64% | 0.60% | 0.66% | 0.42% | 0.89% | 2.09% | 1.38% | 1.25% | -0.06% | 1.13% | 11.83% |
Forecast
Morphic EBITDA Forecast
Quarter
Dec 24 | Sep 24 | Jun 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | - | 18 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 8 |
EBITDA | - | - | - | - | $-44.75M | - | $-39.20M | $-26.34M | $-31.24M | $26.60M | $-31.41M | $-20.42M | $-24.72M | $-27.53M | $-21.00M | $-17.51M | $5.75M | $-15.32M | $-15.73M | $-18.15M | $-8.35M | $-9.10M |
Avg Forecast | $-734.30K | $-244.77K | - | $-25.79M | $-1.31M | $-2.35M | $-27.58M | $-15.59M | $-3.41M | $-3.58M | $-29.50M | $-14.55M | $-5.08M | $-5.68M | $-17.95M | $-6.48M | $-12.04M | $-5.46M | $-13.44M | $-5.65M | $-4.92M | $-80.46M |
High Forecast | $-734.30K | $-244.77K | - | $-20.63M | $-1.31M | $-2.35M | $-22.07M | $-12.47M | $-3.41M | $-3.58M | $-23.60M | $-14.55M | $-5.08M | $-5.68M | $-14.36M | $-6.48M | $-12.04M | $-5.46M | $-10.75M | $-5.65M | $-4.92M | $-64.37M |
Low Forecast | $-734.30K | $-244.77K | - | $-30.95M | $-1.31M | $-2.35M | $-33.10M | $-18.71M | $-3.41M | $-3.58M | $-35.40M | $-14.55M | $-5.08M | $-5.68M | $-21.53M | $-6.48M | $-12.04M | $-5.46M | $-16.13M | $-5.65M | $-4.92M | $-96.55M |
Surprise % | - | - | - | - | 34.28% | - | 1.42% | 1.69% | 9.16% | -7.43% | 1.06% | 1.40% | 4.86% | 4.85% | 1.17% | 2.70% | -0.48% | 2.81% | 1.17% | 3.21% | 1.70% | 0.11% |
Forecast
Morphic Net Income Forecast
Quarter
Dec 24 | Sep 24 | Jun 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | - | 18 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 8 |
Net Income | - | - | - | - | $-36.21M | - | $-36.13M | $-24.38M | $-30.02M | $26.84M | $-31.30M | $-21.97M | $-25.04M | $-27.82M | $-21.28M | $-17.75M | $5.35M | $-15.86M | $-16.75M | $-19.83M | $-8.86M | $-9.43M |
Avg Forecast | $-50.60M | $-46.92M | $-50.10M | $-26.16M | $-47.77M | $-43.69M | $-27.98M | $-16.34M | $-41.58M | $-42.27M | $-29.93M | $-24.63M | $-36.37M | $-27.35M | $-18.19M | $-25.05M | $-21.44M | $-28.05M | $-14.30M | $-20.16M | $-19.91M | $-83.41M |
High Forecast | $-50.60M | $-40.34M | $-50.10M | $-20.93M | $-41.24M | $-43.69M | $-22.39M | $-13.07M | $-41.58M | $-42.27M | $-23.94M | $-24.63M | $-36.37M | $-27.35M | $-14.55M | $-25.05M | $-21.44M | $-28.05M | $-11.44M | $-20.16M | $-19.91M | $-66.73M |
Low Forecast | $-50.60M | $-52.62M | $-50.10M | $-31.40M | $-58.34M | $-43.69M | $-33.58M | $-19.60M | $-41.58M | $-42.27M | $-35.92M | $-24.63M | $-36.37M | $-27.35M | $-21.83M | $-25.05M | $-21.44M | $-28.05M | $-17.16M | $-20.16M | $-19.91M | $-100.09M |
Surprise % | - | - | - | - | 0.76% | - | 1.29% | 1.49% | 0.72% | -0.64% | 1.05% | 0.89% | 0.69% | 1.02% | 1.17% | 0.71% | -0.25% | 0.57% | 1.17% | 0.98% | 0.45% | 0.11% |
Forecast
Morphic SG&A Forecast
Quarter
Dec 24 | Sep 24 | Jun 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | - | 18 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 8 |
SG&A | - | - | - | - | $10.38M | - | $9.28M | $8.01M | $8.30M | $8.23M | $7.59M | $7.44M | $7.28M | $7.14M | $5.95M | $5.13M | $4.75M | $4.20M | $4.42M | $3.43M | $2.90M | $2.08M |
Avg Forecast | $11.61M | $3.87M | - | $30.64M | $20.64M | $37.21M | $33.41M | $47.06M | $53.92M | $56.56M | $58.10M | $230.00M | $80.34M | $89.78M | $5.09M | $102.46M | $190.38M | $86.27M | $3.78M | $89.26M | $77.78M | $7.29M |
High Forecast | $11.61M | $3.87M | - | $36.77M | $20.64M | $37.21M | $33.41M | $47.06M | $53.92M | $56.56M | $58.10M | $230.00M | $80.34M | $89.78M | $6.10M | $102.46M | $190.38M | $86.27M | $4.53M | $89.26M | $77.78M | $8.74M |
Low Forecast | $11.61M | $3.87M | - | $24.51M | $20.63M | $37.21M | $33.41M | $47.06M | $53.92M | $56.56M | $58.10M | $230.00M | $80.34M | $89.78M | $4.07M | $102.46M | $190.38M | $86.27M | $3.02M | $89.26M | $77.78M | $5.83M |
Surprise % | - | - | - | - | 0.50% | - | 0.28% | 0.17% | 0.15% | 0.15% | 0.13% | 0.03% | 0.09% | 0.08% | 1.17% | 0.05% | 0.02% | 0.05% | 1.17% | 0.04% | 0.04% | 0.29% |
Forecast
Morphic EPS Forecast
Quarter
Dec 24 | Sep 24 | Jun 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | - | 18 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 8 |
EPS | - | - | - | - | $-0.74 | - | $-0.90 | $-0.64 | $-0.78 | $0.70 | $-0.84 | $-0.60 | $-0.69 | $-0.77 | $-0.63 | $-0.58 | $0.18 | $-0.52 | $-0.55 | $-0.66 | $-0.30 | $-4.73 |
Avg Forecast | $-1.01 | $-0.94 | $-1.00 | $-0.94 | $-0.95 | $-0.87 | $-0.81 | $-0.87 | $-0.83 | $-0.84 | $-0.81 | $-0.49 | $-0.73 | $-0.55 | $-0.55 | $-0.50 | $-0.43 | $-0.56 | $-0.48 | $-0.40 | $-0.40 | $-3.54 |
High Forecast | $-1.01 | $-0.81 | $-1.00 | $-0.94 | $-0.82 | $-0.87 | $-0.81 | $-0.87 | $-0.83 | $-0.84 | $-0.81 | $-0.49 | $-0.73 | $-0.55 | $-0.55 | $-0.50 | $-0.43 | $-0.56 | $-0.48 | $-0.40 | $-0.40 | $-2.83 |
Low Forecast | $-1.01 | $-1.05 | $-1.00 | $-0.94 | $-1.16 | $-0.87 | $-0.81 | $-0.87 | $-0.83 | $-0.84 | $-0.81 | $-0.49 | $-0.73 | $-0.55 | $-0.55 | $-0.50 | $-0.43 | $-0.56 | $-0.48 | $-0.40 | $-0.40 | $-4.24 |
Surprise % | - | - | - | - | 0.78% | - | 1.11% | 0.73% | 0.94% | -0.83% | 1.04% | 1.22% | 0.95% | 1.41% | 1.15% | 1.16% | -0.42% | 0.93% | 1.15% | 1.63% | 0.75% | 1.34% |
Forecast
Morphic Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
VTYX | Ventyx Biosciences | $1.72 | $33.86 | 1868.60% | Buy |
INZY | Inozyme Pharma | $2.79 | $14.67 | 425.81% | Buy |
PLRX | Pliant Therapeutics | $12.73 | $39.71 | 211.94% | Buy |
ETNB | 89bio | $7.98 | $22.00 | 175.69% | Buy |
STOK | Stoke Therapeutics | $11.31 | $30.60 | 170.56% | Buy |
TERN | Terns Pharmaceuticals | $5.60 | $14.25 | 154.46% | Buy |
IMCR | Immunocore | $32.42 | $70.75 | 118.23% | Buy |
VKTX | Viking Therapeutics | $51.53 | $102.40 | 98.72% | Buy |
AKRO | Akero Therapeutics | $30.64 | $46.00 | 50.13% | Buy |
PCVX | Vaxcyte | $85.96 | $124.00 | 44.25% | Buy |
DICE | DICE Therapeutics | $47.55 | $60.00 | 26.18% | Buy |
RNA | Avidity Biosciences | $43.65 | $54.50 | 24.86% | Buy |
PTGX | Protagonist Therapeutics | $40.65 | $50.00 | 23.00% | Buy |
RVMD | Revolution Medicines, Inc. Warrant | $57.07 | $60.63 | 6.24% | Buy |
MORF | Morphic | $56.99 | $57.00 | 0.02% | Hold |
MDGL | Madrigal Pharmaceuticals | $317.09 | $315.75 | -0.42% | Buy |
ACLX | Arcellx | $87.22 | $83.00 | -4.84% | Buy |